Ozempic from India Now Available to US Patients at Steep Discount

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorKavya Nair|Published at:
Ozempic from India Now Available to US Patients at Steep Discount
Overview

Canadian pharmacy SaveRxCanada.to is offering Novo Nordisk's Ozempic, sourced from India, to U.S. patients at significantly lower prices, reportedly around $280 per pen compared to U.S. retail costs of $900-$1,100. The move addresses growing demand for cheaper prescription drugs. However, manufacturer Novo Nordisk stated it has no relationship with the platform and has not supplied Ozempic from India to them, while U.S. health officials advise caution when buying medicines online.

India-Sourced Ozempic Reaches US Patients

Canadian online pharmacy SaveRxCanada.to announced Wednesday it is now offering Novo Nordisk's popular diabetes and weight-loss drug Ozempic to U.S. patients. The crucial distinction is that these injections are sourced from India, presenting a significant price advantage.

Price Disparity Fuels Demand

The platform states India-sourced Ozempic pens start at approximately $280. This price point drastically contrasts with U.S. retail pharmacies, where Ozempic typically ranges from $900 to $1,100 per pen, depending on the dosage and location. This substantial cost difference is attributed to rising out-of-pocket expenses for many American consumers. SaveRxCanada.to describes itself as an international prescription referral service with 24 years of operation.

Manufacturer Denies Involvement

Novo Nordisk, the Denmark-based manufacturer of Ozempic, has publicly distanced itself from the Canadian platform's claims. A spokesperson stated on Thursday that the company has "no customer or partner relationship with this company/platform, and Ozempic from India has not been provided to them." The exact method by which SaveRxCanada.to is obtaining the medication remains unclear, as the company declined to comment when contacted directly.

Regulatory Scrutiny Looms

Officials from the U.S. Department of Health and Human Services declined to comment on SaveRxCanada.to's distribution claims. They instead directed consumers to the Food and Drug Administration's (FDA) BeSafeRx resource, which offers guidance on safely purchasing prescription medicines online. The platform requires a valid prescription for all orders and advertises free shipping.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.